Revolade 25 mg 28 Tablet

Revolade ® 50 mg 14 film-coated tablets revolade Eltrombopag is sold under the brand name Revolade outside the US and is marketed by Novartis It is a thrombopoietin receptor agonist It is taken by mouth revolade Revolade is the first approved therapy in the EU for patients with severe aplastic anemia who have not responded to other treatments

revolade Initial dose regimen: Adults: Revolade should be initiated at a dose of 25 mg once daily For chronic HCV patients of East-Southeast-Asian ancestry, Revolade